On April 25, the following stocks were determined to be overbought: Ardea Biosciences, Inc, and Human Genome Sciences Inc. The demand for these stocks have pushed the prices of the underlying assets to levels that do not support the fundamentals. This is interpreted as a sign that the stocks are overvalued and may experience a pullback.
Shares of Ardea Biosciences, Inc (RDEA) fell by 0.09% or $-0.03/share to $31.62. In the past year, the shares have traded as low as $13.15 and as high as $31.66. On average, 800390 shares of RDEA exchange hands on a given day and today's volume is recorded at 683962.
Shares of Human Genome Sciences Inc (HGSI) traded higher by 0.14% or $0.02/share to $14.66. In the past year, the shares have traded as low as $6.51 and as high as $30.00. On average, 9198530 shares of HGSI exchange hands on a given day and today's volume is recorded at 859724.